These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 7773578)

  • 21. Current prospects for the treatment of clinical sepsis.
    Suffredini AF
    Crit Care Med; 1994 Jul; 22(7):S12-8. PubMed ID: 8026188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current status of clinical trials with anti-TNF.
    Porter SB
    Chest; 1997 Dec; 112(6 Suppl):339S-341S. PubMed ID: 9400899
    [No Abstract]   [Full Text] [Related]  

  • 23. [Sepsis. 2].
    Mayer J
    Vnitr Lek; 1994 Sep; 40(9):614-8. PubMed ID: 7975368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cytokine inhibitors in intensive care].
    Villard J; Jolliet P; Chevrolet JC
    Rev Mal Respir; 1995; 12(4):335-42. PubMed ID: 7481045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current recommendations for diagnosis and management of sepsis and septic shock.
    Smith JS
    JAAPA; 2013 Oct; 26(10):42-5. PubMed ID: 24201922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sepsis and Septic Shock: Lingering Questions.
    Dumont T; Francis-Frank L; Chong J; Balaan MR
    Crit Care Nurs Q; 2016; 39(1):3-13. PubMed ID: 26633153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How to guide volume expansion in severe sepsis and septic shock patients? Possibilities in the real world.
    Westphal GA
    Shock; 2013 May; 39 Suppl 1():38-41. PubMed ID: 23481501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time- and fluid-sensitive resuscitation for hemodynamic support of children in septic shock: barriers to the implementation of the American College of Critical Care Medicine/Pediatric Advanced Life Support Guidelines in a pediatric intensive care unit in a developing world.
    Oliveira CF; Nogueira de Sá FR; Oliveira DS; Gottschald AF; Moura JD; Shibata AR; Troster EJ; Vaz FA; Carcillo JA
    Pediatr Emerg Care; 2008 Dec; 24(12):810-5. PubMed ID: 19050666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the effects of albumin and crystalloid on mortality in adult patients with severe sepsis and septic shock: a meta-analysis of randomized clinical trials.
    Xu JY; Chen QH; Xie JF; Pan C; Liu SQ; Huang LW; Yang CS; Liu L; Huang YZ; Guo FM; Yang Y; Qiu HB
    Crit Care; 2014 Dec; 18(6):702. PubMed ID: 25499187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjunctive therapy for septic shock: a review of experimental approaches.
    Lynn WA; Cohen J
    Clin Infect Dis; 1995 Jan; 20(1):143-58. PubMed ID: 7727640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Severe sepsis and septic shock].
    Tønnesen E; Larsen K
    Ugeskr Laeger; 2014 Jul; 176(28):V03130200. PubMed ID: 25292001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimum treatment of severe sepsis and septic shock: evidence in support of the recommendations.
    Balk RA
    Dis Mon; 2004 Apr; 50(4):168-213. PubMed ID: 15133467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concise Review: Mesenchymal Stromal/Stem Cells: A New Treatment for Sepsis and Septic Shock?
    Laroye C; Gibot S; Reppel L; Bensoussan D
    Stem Cells; 2017 Dec; 35(12):2331-2339. PubMed ID: 28856759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of severe sepsis and septic shock by CHDF using a PMMA membrane hemofilter as a cytokine modulator.
    Nakamura M; Oda S; Sadahiro T; Hirayama Y; Watanabe E; Tateishi Y; Nakada TA; Hirasawa H
    Contrib Nephrol; 2010; 166():73-82. PubMed ID: 20472994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endotoxin, sepsis, and the primrose path.
    O'Reilly M; Newcomb DE; Remick D
    Shock; 1999 Dec; 12(6):411-20. PubMed ID: 10588508
    [No Abstract]   [Full Text] [Related]  

  • 36. Is the current management of severe sepsis and septic shock really evidence based?
    Vincent JL
    PLoS Med; 2006 Sep; 3(9):e346. PubMed ID: 16933970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The problems and challenges of immunotherapy in sepsis.
    Nasraway SA
    Chest; 2003 May; 123(5 Suppl):451S-9S. PubMed ID: 12740228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of IgM and IgA-enriched immunoglobulins in the treatment of severe sepsis and septic shock. Clinical experience.
    Berlot G; Dimastromatteo G
    Minerva Anestesiol; 2004 Oct; 70(10):739-43; 743-5. PubMed ID: 15516885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of early goal-directed therapy on mortality in patients with severe sepsis or septic shock: a Meta analysis].
    Xing L; Tong L; Jun L; Xinjing G; Lei X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Sep; 27(9):735-8. PubMed ID: 26955699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early identification and management of patients with severe sepsis and septic shock in the emergency department.
    Keegan J; Wira CR
    Emerg Med Clin North Am; 2014 Nov; 32(4):759-76. PubMed ID: 25441033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.